WO2000008143A3 - Gene isolated on the short arm of human chromosome 17 - Google Patents
Gene isolated on the short arm of human chromosome 17 Download PDFInfo
- Publication number
- WO2000008143A3 WO2000008143A3 PCT/DE1999/002479 DE9902479W WO0008143A3 WO 2000008143 A3 WO2000008143 A3 WO 2000008143A3 DE 9902479 W DE9902479 W DE 9902479W WO 0008143 A3 WO0008143 A3 WO 0008143A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- short arm
- dna molecules
- human chromosome
- vectors
- gene isolated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU64629/99A AU6462999A (en) | 1998-08-07 | 1999-08-06 | Gene isolated on the short arm of human chromosome 17 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19835910.1 | 1998-08-07 | ||
DE19835910A DE19835910C1 (en) | 1998-08-07 | 1998-08-07 | Gene isolated on the short arm of human chromosome 17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000008143A2 WO2000008143A2 (en) | 2000-02-17 |
WO2000008143A3 true WO2000008143A3 (en) | 2000-06-15 |
Family
ID=7876883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE1999/002479 WO2000008143A2 (en) | 1998-08-07 | 1999-08-06 | Gene isolated on the short arm of human chromosome 17 |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU6462999A (en) |
DE (1) | DE19835910C1 (en) |
WO (1) | WO2000008143A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7033790B2 (en) | 2001-04-03 | 2006-04-25 | Curagen Corporation | Proteins and nucleic acids encoding same |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999015639A1 (en) * | 1997-09-19 | 1999-04-01 | Mcgill University | Polymorphic cag repeat-containing gene and uses thereof |
-
1998
- 1998-08-07 DE DE19835910A patent/DE19835910C1/en not_active Expired - Fee Related
-
1999
- 1999-08-06 WO PCT/DE1999/002479 patent/WO2000008143A2/en active Application Filing
- 1999-08-06 AU AU64629/99A patent/AU6462999A/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999015639A1 (en) * | 1997-09-19 | 1999-04-01 | Mcgill University | Polymorphic cag repeat-containing gene and uses thereof |
Non-Patent Citations (6)
Title |
---|
DATABASE EMESTS E.M.B.L Databases; 6 April 1998 (1998-04-06), PHILIBERT R ET AL: "Homo sapiens trinucleotide repeat ctg-37", XP002130828 * |
DATABASE GENESEQ E.M.B.L Databases; 25 June 1999 (1999-06-25), BENKELFAT C ET AL: "Human hGT1 DNA", XP002130829 * |
IMAI Y ET AL: "Cloning of a retinoic acid-induced gene, GT1, in the embryonal carcinoma cell line P19: neuron-specific expression in the mouse brain", BRAIN RES MOL BRAIN RES, vol. 31, no. 1-2, July 1995 (1995-07-01), pages 1 - 9, XP002093328 * |
PHILIBERT R ET AL: "The characterization and sequence analysis of thirty CTG-repeat containing genomic cosmid clones", EUR J HUM GENET, vol. 6, no. 1, January 1998 (1998-01-01), pages 89 - 94, XP002093332 * |
SERANSKI P ET AL: "Molecular analysis of the human chromosome 17p11.2: From breakpoint identification to sequencing and gene analysis", J. MOL. MED., vol. 76, no. 6, May 1998 (1998-05-01), pages B38 - P143, XP002130827 * |
WILGENBUS K ET AL: "Molecular characterization of a genetically unstable region containing the SMS critical area and a breakpoint cluster for human PNETs", GENOMICS, vol. 42, no. 1, 15 May 1997 (1997-05-15), pages 1 - 10, XP000876831 * |
Also Published As
Publication number | Publication date |
---|---|
DE19835910C1 (en) | 2000-05-04 |
AU6462999A (en) | 2000-02-28 |
WO2000008143A2 (en) | 2000-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999033982A3 (en) | Human genes and gene expression products i | |
WO1999058675A3 (en) | Human genes and gene expression products v | |
WO1999038972A3 (en) | Human genes and gene expression products ii | |
EP1005540A4 (en) | Ikk-beta proteins, nucleic acids and methods | |
CY1107552T1 (en) | LY6H GENE | |
CA2383926A1 (en) | Functional genomics using zinc finger proteins | |
WO1999053061A3 (en) | Tumor associated nucleic acids and uses therefor | |
CA2295999A1 (en) | Nik proteins, nucleic acids and methods | |
WO2002014500A3 (en) | Human genes and gene expression products | |
WO2001066753A3 (en) | Human genes and gene expression products | |
WO1997003192A3 (en) | Chromosome 1 gene and gene products related to alzheimer's disease | |
WO1997020933A3 (en) | Mutational variants of mammalian ob gene proteins | |
EP0744408A3 (en) | Rhesus ob protein and DNA | |
ATE277171T1 (en) | IKK-ALPHA PROTEINS, NUCLEIC ACIDS AND METHODS | |
WO1999054349A3 (en) | Dermatophagoides nucleic acid molecules, proteins and uses thereof | |
EP1097993A3 (en) | Functional ribozyme chimeric molecules capable of sliding | |
WO2000008143A3 (en) | Gene isolated on the short arm of human chromosome 17 | |
WO2001059120A3 (en) | Il-17 like molecules and uses thereof | |
AU2001238064A1 (en) | 18477, a human protein kinase and uses therefor | |
WO2000018916A3 (en) | Human genes and gene expression products | |
WO2001014415A3 (en) | Egfh2 genes and gene products | |
WO1996038556A3 (en) | Deltap62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancer | |
EP0854187A3 (en) | Novel glucose 6-phosphate dehydrogenase gene | |
WO1999054449A3 (en) | Dyskerine and dyskerine coding dna molecule, vectors containing the same, antibodies against dyskerin and utilization of said elements | |
CA2188264A1 (en) | Isolated nucleic acid molecule coding for fibroblast activation protein .alpha. and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref country code: AU Ref document number: 1999 64629 Kind code of ref document: A Format of ref document f/p: F |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
122 | Ep: pct application non-entry in european phase |